IL-22 a member of a group of cytokines called the IL-10 family or IL-10 superfamily (including IL-19, IL-20, IL-24, and IL-26), a class of potent mediators of cellular inflammatory responses. It shares use of IL-10R2 in cell signaling with other members of this family, IL-10, IL-26, IL-28A/B and IL-29. IL-22 is produced by activated DC and T cells and initiates innate immune responses against bacterial pathogens especially in epithelial cells such as respiratory and gut epithelial cells. IL-22 along with IL-17 is rapidly produced by splenic LTi-like cells  and can be also produced by Th17 cells and likely plays a role in the coordinated response of both adaptive and innate immune systems.
IL-22 biological activity is initiated by binding to a cell-surface complex composed of IL-22R1 and IL-10R2 receptor chains and further regulated by interactions with a soluble binding protein, IL-22BP, which shares sequence similarity with an extracellular region of IL-22R1 (sIL-22R1). IL-22 and IL-10 receptor chains play a role in cellular targeting and signal transduction to selectively initiate and regulate immune responses. IL-22 can contribute to immune disease through the stimulation of inflammatory responses, S100s and defensins. IL-22 also promotes hepatocyte survival in the liver and epithelial cells in the lung and gut similar to IL-10. In some contexts, the pro-inflammatory versus tissue-protective functions of IL-22 are regulated by the often co-expressed cytokine IL-17A 
IL-22, signals through the interferon receptor-related proteins CRF2-4 and IL-22R. It forms cell surface complexes with IL-22R1 and IL-10R2 chains resulting in signal transduction through receptor, IL-10R2. The IL-22/IL-22R1/IL-10R2 complex activates intracellular kinases (JAK1, Tyk2, and MAP kinases) and transcription factors, especially STAT3. It can induce IL-20 and IL-24 signaling when IL-22R1 pairs with IL-20R2.
Crystallization is possible if the N-linked glycosylation sites are removed in mutants of IL-22 bound with high-affinity cell-surface receptor sIL-22R1. The crystallographic asymmetric unit contained two IL-22-sIL-22R1 complexes.
^Dumoutier L, Van Roost E, Colau D, Renauld JC (August 2000). "Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor". Proc. Natl. Acad. Sci. U.S.A.97 (18): 10144–9. doi:10.1073/pnas.170291697. PMC27764. PMID10954742.
^ abXie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, Stinson J, Wood WI, Goddard AD, Gurney AL (October 2000). "Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R". J. Biol. Chem.275 (40): 31335–9. doi:10.1074/jbc.M005304200. PMID10875937.
^Witte K, Witte E, Sabat R, Wolk K (Aug 2010). "IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties". Cytokine Growth Factor Rev21 (4): 237–51. doi:10.1016/j.cytogfr.2010.04.002. PMID20655797.
^Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, Ivanov II, Littman DR, O'Shea JJ. (2009). "Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22.". J Exp Med.206 (1): 35–41. doi:10.1084/jem.20072713. PMC2626689. PMID19114665.
Davila S, Froeling FE, Tan A, et al. (2010). "New genetic associations detected in a host response study to hepatitis B vaccine". Genes Immun.11 (3): 232–8. doi:10.1038/gene.2010.1. PMID20237496.
Silverberg MS, Cho JH, Rioux JD, et al. (2009). "Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study". Nat. Genet.41 (2): 216–20. doi:10.1038/ng.275. PMC2652837. PMID19122664.
Shen H, Goodall JC, Hill Gaston JS (2009). "Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis". Arthritis Rheum.60 (6): 1647–56. doi:10.1002/art.24568. PMID19479869.
Thompson CL, Plummer SJ, Tucker TC, et al. (2010). "Interleukin-22 genetic polymorphisms and risk of colon cancer". Cancer causes & control : CCC21 (8): 1165–70. doi:10.1007/s10552-010-9542-5. PMID20339910.
Hughes T, Becknell B, McClory S, et al. (2009). "Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22". Blood113 (17): 4008–10. doi:10.1182/blood-2008-12-192443. PMC2673127. PMID19244159.
Siezen CL, Bont L, Hodemaekers HM, et al. (2009). "Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes". Pediatr. Infect. Dis. J.28 (4): 333–5. doi:10.1097/INF.0b013e31818e2aa9. PMID19258923.
Pitta MG, Romano A, Cabantous S, et al. (2009). "IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani". J. Clin. Invest.119 (8): 2379–87. doi:10.1172/JCI38813. PMC2719936. PMID19620772.
Liu Y, Yang B, Zhou M, et al. (2009). "Memory IL-22-producing CD4+ T cells specific for Candida albicans are present in humans". Eur. J. Immunol.39 (6): 1472–9. doi:10.1002/eji.200838811. PMID19449309.
He M, Liang P (2010). "IL-24 transgenic mice: in vivo evidence of overlapping functions for IL-20, IL-22, and IL-24 in the epidermis". J. Immunol.184 (4): 1793–8. doi:10.4049/jimmunol.0901829. PMID20061404.
Wolk K, Witte E, Warszawska K, et al. (2009). "The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis". Eur. J. Immunol.39 (12): 3570–81. doi:10.1002/eji.200939687. PMID19830738.
Eyerich S, Eyerich K, Pennino D, et al. (2009). "Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling". J. Clin. Invest.119 (12): 3573–85. doi:10.1172/JCI40202. PMC2786807. PMID19920355.
Dhiman R, Indramohan M, Barnes PF, et al. (2009). "IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion". J. Immunol.183 (10): 6639–45. doi:10.4049/jimmunol.0902587. PMID19864591.
Cella M, Fuchs A, Vermi W, et al. (2009). "A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity". Nature457 (7230): 722–5. doi:10.1038/nature07537. PMID18978771.